Drugmaker Orion sees inflation hit in H2 after quarterly profit beat
(Reuters) – Finnish drugmaker Orion on Friday reported better-than-expected quarterly earnings helped by strong sales of prostate cancer treatment Nubeqa, but warned cost inflation would hit its profits in the second half of the year.
Drugmaker Orion sees inflation hit in H2 after quarterly profit beat
(Reuters) – Finnish drugmaker Orion on Friday reported better-than-expected quarterly earnings helped by strong sales of prostate cancer treatment Nubeqa, but warned cost inflation would hit its profits in the second half of the year.